摘要
随着对糖尿病病因及发病机制的研究深入,新型降糖药物不断得到开发并先后进入临床。开发新靶点、不良反应少、保护胰岛β细胞功能的新型药物成为当前研究的热点。本文综述胰高血糖素样肽1受体激动剂等几种新型降糖药物的研究进展。
With the study on the etiology and pathogenesis of diabetes, new hypoglycemic agents are constantly being developed and applied. Now to develop the new therapeutic drugs for new targets, less adverse reactions, and for the protection of pancreatic β cells has become a hot research topic in current research. This review describes the current research progress of new hypoglycemic drugs.
出处
《世界临床药物》
CAS
2016年第6期361-365,共5页
World Clinical Drug
关键词
糖尿病
机制
治疗药物
diabetes mellitus
mechanism
therapeutic drug
